Discover 3,059 paid clinical trials in Cambridge, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,059
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
for
Multiple Myeloma
Location: Boston MA, New York NY, Detroit MI, Chapel Hill NC,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05137054
Phase 1, Recruiting
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
for
Psoriatic Arthritis
Location: Worcester MA, New York NY, Philadelphia PA,
Sponsor: University of Pennsylvania
Sex: All
Age: 18 - 70+
Code: NCT05669833
Phase 3, Recruiting
Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
for
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia
Location: Boston MA, Mineola NY, New Hyde Park NY, The Bronx NY,
Sponsor: Hoth Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05639933
Phase 2, Recruiting
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
for
Binge-Eating Disorder
Location: Boston MA, Cromwell CT, Mount Kisco NY, New York NY,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 55
Code: NCT06413433
Phase 3, Recruiting
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
Location: Boston MA, Chicago IL, Aurora CO, Stanford CA,
Sponsor: Sonoma Biotherapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07123038
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Boston MA, South Weymouth MA, Foxborough MA, Methuen MA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase 3, Recruiting
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
for
Triple Negative Breast Cancer
Location: Boston MA, New York NY, Chicago IL, Aurora CO,
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Sex: All
Age: 18+
Code: NCT06908928
Phase 1, Recruiting
Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer
for
Lung Cancer
Location: Boston MA, Los Angeles CA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT06427954
Recruiting
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
for
Venous Thromboembolism
Location: Boston MA, Evanston IL, Jacksonville FL
Sponsor: Manuel Monreal
Sex: All
Age: 0+
Code: NCT02832245
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
for
Androgen Axis Suppression, Prostatectomy, Prostate Cancer
Location: Boston MA, New York NY, Chicago IL, Kansas City KS,
Sponsor: M.D. Anderson Cancer Center
Sex: Male
Age: 18+
Code: NCT06274047
Phase 3, Recruiting
"Prapela® SVS Incubator Pad for Apnea of Prematurity
for
Apnea of Prematurity
Location: Boston MA, Birmingham AL
Sponsor: Tufts Medical Center
Sex: All
Age: 0
Code: NCT06374147
Recruiting
Child and Adolescent Registry for Participants With Narcolepsy
for
Narcolepsy
Location: Boston MA, Manhasset NY, Philadelphia PA, Danville PA,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 0 - 17
Code: NCT04899947
Recruiting
A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4
for
Congenital Myasthenic Syndrome
Location: Boston MA, Philadelphia PA, Ottawa, Columbus OH,
Sponsor: argenx
Sex: All
Age: 2+
Code: NCT06078553
Recruiting
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients